Beth Israel Deaconess Medical Cente — Boston, Massachusetts

Beth Israel Deaconess Medical Cente is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Medical Cente has participated in 4 clinical trials.

Therapeutic areas: Multiple Myeloma, Relapsing Multiple Sclerosis, Idiopathic Pulmonary Fibrosis.

Sponsors: Novartis Pharmaceuticals, Pliant Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Medical Cente?

Beth Israel Deaconess Medical Cente has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Medical Cente conducted?

Beth Israel Deaconess Medical Cente has 4 clinical trials on record. Their work covers Multiple Myeloma, Relapsing Multiple Sclerosis, Idiopathic Pulmonary Fibrosis.

Is Beth Israel Deaconess Medical Cente accredited by Crixeo Health?

Beth Israel Deaconess Medical Cente has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deaconess Medical Cente?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.